1. Introduction
===============

Pyrazolopyrimidinone derivatives have attracted the attention of numerous researchers over many years due to their important biological activities \[[@B1-molecules-15-03079],[@B2-molecules-15-03079],[@B3-molecules-15-03079],[@B4-molecules-15-03079]\]. Structural analogs of pyrazolo\[3,4-*d*\]- pyrimidines have displayed good activities as inhibitors of cyclin-dependent kinase 2 \[[@B5-molecules-15-03079]\] and PI3 kinase-A \[[@B6-molecules-15-03079]\], anticancer and radioprotective activity \[[@B7-molecules-15-03079]\], antimicrobial \[[@B8-molecules-15-03079]\] and other biology activity \[[@B9-molecules-15-03079]\]. The importance of pyrazolo\[3, 4-*d*\]pyrimidines had resulted in the development of several synthetic methods for their construction \[[@B10-molecules-15-03079],[@B11-molecules-15-03079]\]. The traditional transformation utilizes two steps to assemble aminopyrazolo\[3, 4-*d*\] pyrimidin-4-ones, as illustrated in [Scheme 1](#molecules-15-03079-f002){ref-type="fig"} and [Scheme 2](#molecules-15-03079-f003){ref-type="fig"}. However, the transformation of compounds **2** requires two steps and sufferes from several disadvantages such as vigorous conditions, long reaction times and low yields \[[@B12-molecules-15-03079],[@B13-molecules-15-03079]\]. The development of one-step and efficient syntheses of aminopyrazolo\[3,4-*d*\]pyrimidin-4-ones under mild conditions remained a work in progress.

![Synthesis of pyrazolo \[3, 4-*d*\] pyrimidin-4-ones by the reaction of esters.](molecules-15-03079-g002){#molecules-15-03079-f002}

![Synthesis of pyrazolo \[3, 4-*d*\] pyrimidin-4-ones by the reaction of acyl chlorides.](molecules-15-03079-g003){#molecules-15-03079-f003}

Here, we report a simple and efficient method for the synthesis of usefully functionalized pyrazolo\[3,4-d\] pyrimidins-4-ones **2** by heteroannulation under mild conditions using POCl~3~.

2. Result and Discussion
========================

The 5-amino-N-substituted-1H-pyrazole-4-carbonitrile starting materials **1**, synthesized by a one--pot synthesis literature procedure \[[@B14-molecules-15-03079]\], was then reacted with lower aliphatic acids in the presence of POCl~3~ to give the target N-substituted pyrazolo\[3,4-*d*\]pyrimidin-4-ones **2** ([Scheme 3](#molecules-15-03079-f004){ref-type="fig"}).

![Synthesis of pyrazolo\[3, 4-*d*\]pyrimidin-4-ones by the reaction of carboxylic acid in the presence of POCl~3~.](molecules-15-03079-g004){#molecules-15-03079-f004}

A number of works about POCl~3~-catalyzed reactions, especially intramolecular condensations \[[@B15-molecules-15-03079]\] have been reported. In our reaction system POCl~3~ acted not only as a chlorinating reagent, but also an oxidant. Thus, we concluded that the 5-amino-N-substituted-1*H*-pyrazole-4-carbonitrile were first oxidized to give the corresponding N-substituted-5-amino-pyrazole-4-carboxamide, which immediately reacted with the acyl chloride which might be generated *in situ* from the reaction of the carboxylic acid with POCl~3~. Followed by cyclization and condensation of the intermediate, the target products were formed. The reaction went smoothly by controlling the amount of POCl~3~, and the products were obtained in good yields. The results were presented in [Table 1](#molecules-15-03079-t001){ref-type="table"}.

molecules-15-03079-t001_Table 1

###### 

N-substituted prazolo\[3, 4-*d*\]pyrimidin-4-one **2a-j** via [Scheme 3](#molecules-15-03079-f004){ref-type="fig"}.

  Entry                                     R^2^         R^1^                          Yield a   Time(h)
  ----------------------------------------- ------------ ----------------------------- --------- ---------
  **2 a**                                   H            2,6-Cl~2~-4-CF~3~-C~6~H~2~-   90        1.5
  **2 b**                                   CH~3~        2,6-Cl~2~-4-CF~3~-C~6~H~2~-   87        2
  **2 c**                                   CH~2~CH~3~   2,6-Cl~2~-4-CF~3~-C~6~H~2~-   90        2.5
  **2 d**                                   CCl~3~       2,6-Cl~2~-4-CF~3~-C~6~H~2~-   89        2
  **2 e**                                   CH~3~        4-OCH~3~-C~6~H~4~-            83        1
  **2 f**                                   CH~3~        2,4-(NO~2~)~2~-C~6~H~3~-      90        1.5
  **2 g**                                   CH~3~        2,4,6-Cl~3~-C~6~H~2~-         97        1.5
  **2h**                                    CH~3~        2-Cl-C~6~H~4~-                82        2
  **2 i**                                   CH~3~        H                             75        2.5
  **2 j**                                   CH3          n-Bu                          70        2.5
  ^a^ isolated yields based on compound 2                                                        

The structures of compounds **2a-j** were deduced from their elemental analyses and their IR, ^1^H- NMR, ^13^C-NMR and mass spectra and all elemental and spectral data of compounds **2a-j** were in accord with the suggested structures. The ^1^H-NMR spectrum of **2c**, as an example, consisted of a singlet at δ 11.06 from the NH function, a singlet at δ 8.27 is from the H-3 proton, a singlet at δ 8.11 due to the phenyl ring (two protons), a multiplet at δ 2.74 (two protons) from the CH~2~ and a triplet at δ 1.23 due to the methyl group (three protons). Moreover the structure of **2c** was confirmed via X-ray crystallographic analysis ([Figure 1](#molecules-15-03079-f001){ref-type="fig"}).

![Single crystal X-ray crystal structure of **2c**.](molecules-15-03079-g001){#molecules-15-03079-f001}

3. Experimental
===============

3.1. General
------------

All the melting points were uncorrected. ^1^H-, ^13^C-, and ^19^F-NMR spectra were recorded on a FT-Bruker AT-300 instrument using CDCl~3~ or CD~3~COCD~3~ as a solvent with tetramethylsilane (TMS) as the internal standard. J-values are given in Hz. Compounds were properly characterized by elemental analyses using a Carlo-Erba EA-1112 instrument. IR spectra were measured on a Bruker VECTOR55 instrument. Silica gel 60 GF254 was used for analytical and preparative TLC.

3.2. General procedure for the preparation of the pyrazolo\[3,4-d\]pyrimidines ***2a-2j***: preparation of 2c
-------------------------------------------------------------------------------------------------------------

5-Amino-1-\[2,6-dichloro-4-(trifloromethyl)phenyl\]-1*H*-pyrazole-4-carbonitrile (0.321 g, 1 mmol) was dissolved in propanoic acid (3 mL). Then POCl~3~(0.2 mL) was added quickly. The mixture was refluxed for 2 h (the reaction system was carefully observed by TLC). After the mixture was cooled, added ice water (50 mL). A mass of white precipitate was produced. K~2~CO~3~ was added to neutralize the acid till no bubble occurs. The reaction mixture was filtered, and washed with a small amount of ethanol, dried. A 90% yield of the compound was obtained. Crystals of **2c** suitable for X-ray diffraction were obtained by slow evaporation of ethanol-acetone mixture solution. The other compounds were also synthesized according to this method.

*1-(2,6-Dichloro-4-(trifluoromethyphenyl\]-4,5-dihydro-1H-pyrazolo\[3,4-d\]pyrimidin-4-one*(**2a**): White solid; mp 271-273 ºC, IR (KBr, cm^-1^): 3849, 3749, 2924, 1699, 1592, 681;^1^H-NMR (CD~3~COCD~3~, 300 MHz): δ 11.32 (s, 1H), 8.36 (s, 1H), 8.15 (s, 1H), 8.12 (s, 2H); ^13^C-NMR (CD~3~COCD~3~, 75 MHz): δ 106.3 (1C), 122.4 (q, *J* = 272 Hz, 1C), 126.4 (1C), 132.7 (q, *J* = 33.75 Hz, 1C), 135.5 (2C), 136.1 (1C), 137.8 (2C), 149.8 (1C), 153.8 (1C), 157.0 (1C); MS: *m/z* (%) = 348 (100, \[M^+^\]). Anal. Calcd. for C~12~H~5~Cl~2~F~3~N~4~O: C, 41.29; H, 1.44; N, 16.05. Found: C, 41.20; H, 1.45; N, 16.00%.

*6-Methyl-1-(2,6-dichloro-4-trifluoromethylphenyl)-4,5-dihydro-1H-pyrazolo\[3,4-d\]pyrimidin-4-one* (2b): White solid; mp 259-260 ºC, IR (KBr, cm^-1^): 3772, 3105, 2896, 1598, 1392, 1317, 1131; ^1^H-NMR (DMSO-d~6~, 300 MHz): δ 12.42 (s, 1H), 8.40 (s, 1H), 8.27 (s, 2H), 2.31 (s, 3H);^13C^-NMR (DMSO-d~6~, 75 MHz): δ 21.2 (1C), 104.3 (1C), 122.2 (q, *J* = 272 Hz, 1C), 126.4 (1C), 132.6 (q, *J*= 33.70 Hz, 1C), 135.6 (2C), 136.3 (1C), 137.6 (2C), 154.5 (1C), 157.6 (1C), 159.8 (1C); MS: *m/z* (%) = 361 (100, \[M^+^- 1\]); Anal. Calcd for C~13~H~7~Cl~2~F~3~N~4~O: C, 43.00; H, 1.94; N, 15.43. Found: C, 42.91; H, 1.90, N, 15.38.

*6-Ethyl-1-(2,6-dichloro-4-trifluoromethylphenyl)-4,5-dihydro-1H-pyrazolo\[3,4-d\]pyrimidin-4-one*(2c): White solid; mp 232-233 ºC, IR (KBr, cm^-1^): 3094, 2989, 1681, 1598, 1531, 1319, 1173, 1124, ^1^H-NMR (CD~3~COCD~3~, 300 MHz): δ 11.16 (s, 1H), 8.27 (s, 1H), 8.11 (s, 2H), 2.74 (q, *J* = 7.5 Hz, 2H), 1.23 (t, *J* = 7.5 Hz, 3H);^13C^-NMR (DMSO-d~6~, 75 MHz): δ 11.8 (1C), 27.8 (1C), 104.6 (1C), 122.4 (q, *J* = 272 Hz, 1C), 126.5 (1C), 132.7 (q, *J*= 33.75 Hz, 1C), 135.7 (2C), 136.5 (1C), 137.7 (2C), 154.6 (1C), 158.0 (1C), 164.1 (1C); MS: *m/z* (%) = 375 (100, \[M^+^- 1\]); Anal. Calcd for C~14~H~9~Cl~2~F~3~N~4~O: C, 44.59; H, 2.41; N, 14.86. Found: C, 44.51; H, 2.36, N, 14.83.

*6-Trichloromethyl-1-(2,6-dichloro-4-trifluoromethylphenyl)-4,5-dihydro-1H-pyrazolo\[3,4-d\]- pyrimid- in-4-one*(2d): White solid; mp 238-239 ºC, IR (KBr, cm^-1^): 3013, 2920, 1683, 1589, 1333, 1317, 1124, 663,^1^H-NMR (DMSO-d~6~, 300 MHz): *δ* 12.50 (s, 1H), 8.45 (s, 1H), 8.24 (s, 2H);^13C^-NMR (DMSO-d~6~, 75 MHz): 79.0 (1C), 105.6 (1C), 122.6 (q, J = 273 Hz, 1C), 126.8 (1C), 132.9 (q, J = 33.75 Hz, 1C), 136.0 (2C), 137.0 (1C), 138.1 (2C), 155.3 (1C), 159.0 (1C), 164.7 (1C); MS: *m/z* (%) = 463 (100, \[M^+^- 1\]); Anal. Calcd for C~13~H~4~Cl~5~F~3~N~4~O: C, 33.47; H, 0.86; N, 12.01. Found: C, 33.451; H, 0.85, N, 12.05.

*6-Methyl-1-(4-methyloxyphenyl)-4,5-dihydro-1H-pyrazolo\[3,4-d\]pyrimidin-4-one*(2e): White solid, mp 258-260 ºC; IR (KBr, cm^-1^): 3850, 3745, 3618, 2926, 1690 (s), 1518, 1463, 675 ; ^1^H-NMR (DMSO-d~6~, 300 MHz): δ 12.23 (s, 1H), 8.19, (s, 1H), 7.86 (d, *J* = 7.5 Hz, 2H), 7.08 (d, *J* = 7.5 Hz, 2H), 3.80 (s, 3H), 2.37 (s, 3H);^13C^-NMR (DMSO-d~6~, 75 MHz): δ 21.5 (1C), 55.5 (1C), 105.2 (1C), 114.3 (2C), 123.5 (2C), 131.5 (1C), 135.3 (1C), 152.1 (1C), 157.9 (1C), 158.1 (1C), 158.3 (1C); MS: *m/z* (%) = 255 (100, \[M^+^- 1\]); Anal. Calcd for C~13~H~12~N~4~O~2~: C, 60.93; H, 4.72; N, 21.86. Found: C, 60.88; H, 4.68, N, 21.76.

*6-Methyl-1-(2,4-dinitrophenyl)-4,5-dihydro-1H-pyrazolo\[3,4-d\]pyrimidin-4-one* (2f): Yellow solid, mp 229-230ºC; IR (KBr, cm^-1^): 3749, 2921, 1695(s), 1605, 1533, 1348 ; ^1^H-NMR (DMSO-d~6~, 300 MHz): δ 12.52 (s, 1H), 8.85 (s, 1H), 8.70 (d, *J* = 9 Hz, 1H), 8.37 (s, 1H), 8.19 (d, *J* = 9 Hz, 1H), 2.44 (s, 3H); ^13C^-NMR (DMSO-d~6~, 75 MHz): δ 21.5 (1C), 105.6 (1C), 121.3 (1C), 128.5 (1C), 128.8 (1C), 134.1 (1C), 138.4 (1C), 143.3 (1C), 146.1 (1C), 153.9 (1C), 157.5 (1C), 160.1 (1C); MS: *m/z* (%) = 315 (100, \[M^+^- 1\]); Anal. Calcd for C~12~H~8~N~6~O~5~: C, 45.58; H, 2.55; N, 26.58. Found: C, 45.45; H, 2.50, N, 26.46.

*6-Methyl-1-(2,4,6-trichlorophenyl)-4,5-dihydro-1H-pyrazolo\[3,4-d\]pyrimidin-4-one* (2g): White solid, mp 236-237 ºC; IR (KBr, cm^-1^): 3432, 1685, 1599, 1536, 1386, 667; ^1^H-NMR (DMSO-d~6~, 300 MHz): δ 12.4 (s, 1H), 8.3 (s, 1H), 8.0 (s, 2H), 2.3 (s, 3H);^13C^-NMR (DMSO-d~6~, 75 MHz): δ 21.4 (1C), 104.4 (1C), 129.2 (2C), 132.2 (1C), 135.4 (2C), 136.4 (1C), 137.4 (1C), 154.6 (1C), 1587.9 (1C), 159.7 (1C); MS: *m/z* (%) = 327 (100, \[M^+^- 1\]); Anal. Calcd for C~12~H~7~Cl~3~N~4~O: C, 43.73; H, 2.14; N, 17.00. Found: C, 43.67; H, 2.10, N, 16.88.

*6-Methyl-1-(2-chlorophenyl)-4,5-dihydro-1H-pyrazolo\[3,4-d\]pyrimidin-4-one*(2h): White solid, mp 217-219 ºC; IR (KBr, cm^-1^): 3840, 3745, 2929, 1693, 1602, 1520; ^1^H-NMR (DMSO-d~6~, 300 MHz): δ 12.3 (s, 1H), 8.2 (s, 1H), 7.6 (m, 4H), 2.3 (s, 3H); ^13^C-NMR (DMSO-d~6~, 75 MHz): δ 21.2 (1C), 104.2 (1C), 128.1 (1C), 130.2 (2C), 131.2 (1C), 131.4 (1C), 134.9 (1C), 136.0 (1C), 153.9 (1C), 157.9 (1C), 158.8 (1C); MS: *m/z* (%) = 259 (100, \[M^+^- 1\]); Anal. Calcd for C~12~H~9~ClN~4~O: C, 55.29; H, 3.84; N, 21.49. Found: C, 55.12; H, 3.80, N, 21.36.

*6-Methyl-4,5-dihydro-1H-pyrazolo\[3,4-d\]pyrimidin-4-one*(2i): White solid, mp 264-265 ºC; IR (KBr, cm^-1^): 3842, 2925, 2272, 1741, 1645, 1518, 1461, 1391, 1121, 669; ^1^H-NMR (DMSO-d*6*, 300 MHz): *δ*12.03 (s, 1H), 10.36 (s,1H), 8.33 (s, 1H), 2.36 (s, 3H); ^13C^-NMR (DMSO-d~6~, 75 MHz): 22.0(1C), 105.00 (1C), 135.17 (1C), 153.70 (1C), 158.78 (1C), 159.20 (1C); MS: *m/z* (%) = 149 (100, \[M^+^- 1\]); Anal. Calcd for C~6~H~6~N~4~O: C, 48.00; H, 4.03; N, 37.32. Found: C, 47.95; H, 4.00, N, 37.28.

*6-Methyl-1-n-butyl-4,5-dihydro-1H-pyrazolo\[3,4-d\]pyrimidin-4-one*(2j)**,** White solid, mp 144-145 ºC; IR (KBr, cm^-1^):2925, 2855, 1387, 1120, 676; ^1^H-NMR (CD~3~COCD~3~): *δ* 11.60 (s, 1H), 8.44 (s, 1H), 4.20 (t, *J* = 6.8 Hz, 2H), 2.26 (s, 3H), 1.78 (m, *J*= 10.6 Hz, 2H), 1.20 (m, *J* = 7.41Hz, 2H), 0.86 (t, *J* = 7.4 Hz, 3H);^13C^-NMR (CD~3~COCD~3~): 13.36 (1C), 19.09 (1C), 21.43 (1C), 31.50 (1C), 52.1 (1C), 104.73 (1C), 128.46 (1C), 155.52 (1C), 159.24 (1C), 159.32 (1C); MS: *m/z* (%) = 205 (100, \[M^+^- 1\]); Anal. Calcd for C~10~H~14~N~4~O: C, 58.24; H, 6.84; N, 27.16. Found: C, 58.20; H, 6.80, N, 27.10.

3.3. X-ray crystallography
--------------------------

Compound **2c** was subjected to single crystal X-ray crystallography and intensity data were collected at 298(2)K on an Siemens P4 diffractometer and use graphite Monochromated MoK~a~adiation (λ = 0.71073Å). The structure was solved by a direct method using the SHELXL-97 program \[[@B16-molecules-15-03079]\] and refined with the SHELXL-97 program. All H atoms bonded to the C atoms were placed geometrically at the distances of 0.93--0.96Å and included in the refinementin riding motion approximation with U~iso~ (H) = 1.2 or 1.5U~eq~ of the carrier atom. The thermal ellipsoids were plotted with the SHELXL-97 program at 50% probability. The molecular structure is shown in [Figure 1](#molecules-15-03079-f001){ref-type="fig"}. Selected crystal data and structure refinement details are presented in [Table 2](#molecules-15-03079-t002){ref-type="table"}. Selected bond distances and angles are listed in [Table 3](#molecules-15-03079-t003){ref-type="table"}.

CCDC 774536 contains the supplementary crystallographic data for this paper. These data can be obtained free of charge from the Cambridge Crystallographic Data Centre, 12, Union Road, Cambridge, CB2 1EZ, UK; E-mail: <deposit@ccdc.cam.ac.uk>.

molecules-15-03079-t002_Table 2

###### 

Crystal data and structure refinement for C~14~H~9~Cl~2~F~3~N~4~O.

  --------------------------------------- ----------------------------------------
  Empirical formula                       C~14~ H~9~ Cl~2~ F~3~ N~4~ O
  Formula weight                          377.15
  Temperature                             298(2) K
  Wavelength                              0.71073 A
  Crystal system                          Monoclinic
  space group                             P 2/n
  Unit cell dimensions                    a = 13.468(4) A alpha = 90 deg.
  b = 8.234(3) A beta = 112.056(6) deg.   
  c = 15.047(5) A gamma = 90 deg          
  Volume                                  1546.4(9)A^3^
  Z                                       4
  Absorption coefficient                  0.463 mm^-1^
  F(000)                                  760
  Theta range for data collection         2.47° to 25.02°
  Limiting indices                        -16\<=h\<=15, -9\<=k\<=9, -17\<=l\<=14
  Reflections collected / unique          7730 / 2740 \[R(int) = 0.0213\]
  Completeness to theta = 25.02           99.6%
  Absorption correction                   Semi-empirical from equivalents
  Max. and min. transmission              0.9214 and 0.8154
  Refinement method                       Full-matrix least-squares on F^2^
  Data / restraints / parameters          2740 / 0 / 218
  Goodness-of-fit on F\^2                 1.142
  Final R indices \[I\>2sigma(I)\]        R1 = 0.0866, wR2 = 0.2087
  R indices (all data)                    R1 = 0.0945, wR2 = 0.2142
  Largest diff. peak and hole             0.660 and -0.897 e.A^-3^
  --------------------------------------- ----------------------------------------

molecules-15-03079-t003_Table 3

###### 

Selected bond distances (Å) and angles (°) for compound **2c**.

  ------------------ ---------- ------------------ ---------- ----------------- ----------
  F(1)-C(1)          1.341(6)   O(1)-C(10)         1.236(5)   N(1)-C(11)        1.369(6)
  N(2)-C(12)         1.355(6)   N(3)-C(8)          1.310(6)   N(4)-C(8)         1.368(6)
  C(1)-C(2)          1.504(7)   C(2)-C(7)          1.360(7)   C(4)-C(5)         1.388(6)
  C(6)-C(7)          1.377(7)   C(9)-C(10)         1.436(6)   C(9)-C(12)        1.388(6)
  C(11)-N(1)-C(10)   125.1(4)   C(8)-N(3)-C(9)     110.2(4)   C(12)-N(4)-C(5)   127.9(4)
  C(8)-N(4)-C(5)     120.2(3)   C(7)-C(2)-C(3)     120.3(4)   C(3)-C(2)-C(1)    119.3(4)
  C(4)-C(3)-C(2)     119.8(4)   C(6)-C(5)-C(4)     117.3(4)   C(6)-C(5)-N(4)    120.3(4)
  N(3)-C(8)-N(4)     106.8(4)   C(12)-C(9)-C(10)   117.6(4)   N(1)-C(10)-C(9)   112.1(4)
  N(2)-C(11)-N(1)    123.9(4)   N(1)-C(11)-C(13)   115.3(4)   N(2)-C(12)-C(9)   127.9(4)
  ------------------ ---------- ------------------ ---------- ----------------- ----------

4. Conclusions
==============

In summary, we have successfully developed a simple and efficient method for the synthesis of variously functionalized pyrazolo\[3,4-d\]pyrimidin-4-ones by heteroannulation under mild conditions using POCl~3~. This works has been patented \[[@B17-molecules-15-03079]\]. Further heteroannulation studies are underway in our laboratory.
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